Loading chat...
IN SB0338
Bill
Status
1/4/2018
Primary Sponsor
James Merritt
Click for details
AI Summary
-
Transfers drug take back program administration from the Indiana Board of Pharmacy to the State Department of Health, effective July 1, 2018.
-
Requires pharmaceutical manufacturers to operate an approved drug take back program individually or jointly, designate an agent to operate a program, or participate in an alternative plan funded by manufacturer contributions.
-
Drug take back programs must include at least two collection methods (mail-back, kiosks, drop-off events, in-home disposal, or DEA-approved alternatives) with security provisions, public outreach, and free consumer use without charges.
-
Program operators must file annual reports describing activities, volume and type of drugs collected, and any other information required by the state department; noncompliance can result in civil penalties with 90 days to correct.
-
Establishes the Drug Take Back Fund administered by the state department, funded by pharmaceutical manufacturer contributions, general assembly appropriations, interest, and donations for medication disposal expenses.
Legislative Description
Drug take back program and drug manufacturers. Transfers the powers of administering a drug take back program from the Indiana board of pharmacy to the state department of health (state department). Requires the state department to implement a drug take back program (program) and sets forth requirements. Requires a pharmaceutical manufacturer to: (1) operate a program individually or jointly with another pharmaceutical manufacturer; (2) enter into an agreement with another entity to act as the pharmaceutical manufacturer's agent and operate a program; or (3) operate an alternative plan to assist in funding programs. Sets forth requirements of a program. Requires
Last Action
Senator Charbonneau added as second author
1/11/2018